Urogenital Chlamydia trachomatis in the environment of soldiers from the Polish Special Forces
More details
Hide details
Department of Epidemiology and Tropical Medicine, Military Institute of Medicine, Warsaw, Poland
Introduction and objective:
Urogenital Chlamydia trachomatis is one of the most common sexually transmitted bacterial pathogens. The aim of the study was to present the current occurrence of chlamydial infections among Polish soldiers, sexually-active men and women at reproductive age.

Material and methods:
The research involved 253 active duty soldiers from the Polish Special Forces, 237 men and 16 women aged 26–57, stationed in Warsaw between October – November 2016. The study participants were asked to fill a socio-demographic questionnaire and then subjected to diagnostic tests. These included a urine test for the presence of Chlamydia trachomatis DNA using the Real-Time PCR assay with fluorescently labeled markers and probes, complementary to plasmid DNA of the bacteria (DNA isolated from urine samples was used as matrix).

Chlamydia trachomatis infection was detected in two male soldiers, non-commissioned officers, at mean age 40.5 years (total: 38.0 years); reporting sexual contacts with 2–3 partners in the last 12 months (total: 141 soldiers – 1 partner, 66 – 2–3 partners, 46 – >4 partners), with no UTI symptoms.

Among all the study participants, of whom more than 40% reported sexual contacts with 2–4 or more partners within the last 12 months, only 0.8% were found to be infected. The low prevalence of Chlamydia trachomatis infection can be associated with a regular or frequent use of STI prevention measures during casual sex, or having a single sexual partner.

Krzysztof Korzeniewski   
Military Institute of Medicine, Department of Epidemiology and Tropical Medicine, Szaserów St. 128, 04-141 Warszawa, Poland
1. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR 2010; 59: 1–116.
2. Cates W, Steiner M. Dual protection against unintended pregnancy and sexually transmitted infections: what is the best contraceptive approach? Sex Transm Dis 2002; 293: 168–74.
3. Althaus C, Heijne J, Low N. Towards more robust estimates of the transmissibility of Chlamydia trachomatis. Sex Trans Dis 2012; 39: 402–4. 0b013e318248a550.
4. World Health Organization. Sexually transmitted infections (STIs), fact sheet No 110. Geneva: WHO; 2015.
5. Global Infectious Diseases and Epidemiology Network. Chlamydia Infections, Worldwide. Available at: Access: 29 Aug 2017.
6. Ahmadi MH, Mirsalehian A, Bahador A. Association of Chlamydia trachomatis with infertility and clinical manifestations: a systematic review and meta-analysis of case-control studies. Infect Dis. (Lond) 2016; 48(7): 517–23. 23744235. 2016.1160421.
7. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010; 201(Suppl2): S134–55.
8. Cunningham KA, Beagley KW. Male genital tract chlamydial infection: implications for pathology and infertility. Biol Reprod. 2008; 79: 180–9. biolreprod. 108.067835.
9. Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015. Lancet 2016; 388(10053): 1545–1602. S0140-6736(16)31678-6.
10. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2015. Atlanta, GA: Department of Health and Human Services; October 2016.
11. Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS One 2015; 10(12): e0143304.
12. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013; 40(30): 187–93. OLQ.0b013e318286 bb53.
13. Dielissen PW, Teunissen DA, Lagro-Janssen AL. Chlamydia prevalence in the general population: is there a sex difference? a systematic review. BMC Infect Dis. 2013; 13: 534.
14. Association of Public Health Laboratories. Laboratory Diagnostic Testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Consultation Meeting Summary Report. January 13–15, 2009. Atlanta, GA.
15. Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med. 2005; 142: 914–25.
16. Lee SE, Nauschuetz W, Jordan N, Lindler L, Steece R, Pfau E, et al. Survey of sexually transmitted disease laboratory methods in US Army laboratories. Sex Transm Dis. 2010; 37(1): 44–8.
17. Berg SW. Sexually Transmitted Diseases and Human Immunodeficiency Virus Infection. In: Kelley PW (Ed.). Military Preventive Medicine: Mobilization and Deployment. Borden Institute Walter Reed Army Medical Center, Office of the Surgeon General at TMM Publications. Vol. 2. Washington DC, USA 2005, pp. 1146–75.
18. Cecil JA, Howell MR, Tawes JJ, Gaydos JC, McKee KT, Quinn TC, et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. J Infect Dis. 2001; 184(9): 1216–19.
19. Hakre S, Oyler RJ, Ferrell KA, Li F, Michael NL, Scott PT, et al. Chlamydia trachomatis infection rates a cohort of mobile soldiers stationed at Fort Bragg, North Carolina, 2005–2010. BMC Public Health 2014; 14: 181. 1471-2458-14-181.
20. Armed Forces Health Surveillance Center. Defense Medical Epidemiology Database. Available from: Accessed: 30 Aug 2017.
21. Korzeniewski K, Konior M, Lass A, Guzek A. Occurrence of Chlamydia trachomatis in military environment on the example of professional soldiers in the Polish Armed Forces. In Marit Health. 2014; 65(3): 137–41.
22. National Institute of Public Health – National Institute of Hygiene. Infectious diseases and poisonings in Poland in 2016. Available at: epimeld/2016/index_mp.html. Access: 30 Aug 2017 [in Polish].